Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2023-10-26 Governance Information
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled as the "Independent Director Work System" of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the governance structure, duties, rights, nomination, election, and replacement procedures of independent directors. It references company laws, securities laws, and stock exchange rules, focusing on governance practices rather than financial data or meeting results. There is no indication of financial statements, audit results, earnings, or shareholder voting outcomes. The document is a governance-related policy or internal rules document. Therefore, it fits best under Governance Information (CGR). The document length (7067 characters) and detailed content support it being a full governance report rather than a brief announcement or regulatory filing.
2023-10-26 Chinese
关于拟修订《公司章程》公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding proposed amendments to the company's Articles of Association (公司章程). It includes extensive text about the nomination, qualifications, and duties of independent directors, board meeting procedures, and other governance-related provisions. The document references relevant laws and stock exchange rules, and it is issued by the company's board of directors. There is no financial data, earnings information, or audit content. The document is not a report itself but a formal announcement of proposed governance changes to be approved by shareholders. Therefore, it fits best under Governance Information (CGR). The document length and detail confirm it is not a brief announcement or a simple notice but a substantive governance document.
2023-10-26 Chinese
第三届董事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 13th meeting of the 3rd Board of Directors of Inner Mongolia Datang Pharmaceutical Co., Ltd. It includes meeting details, attendance, and voting results on various proposals such as approval of the 2023 Q3 report, changes in audit committee members, amendments to company bylaws, and governance rules. The document references other announcements and reports published separately on the official exchange platform, indicating this document itself is a board meeting resolution announcement rather than the reports or documents themselves. The content focuses on board decisions and governance matters, not on financial results or full reports. Therefore, the document fits best under Board/Management Information (MANG). The document length is 3180 characters, which is consistent with a meeting resolution announcement rather than a full report.
2023-10-26 Chinese
董事会审计委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Work Rules of the Board Audit Committee' of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the composition, responsibilities, decision-making procedures, and meeting rules of the audit committee, which is a specialized board committee. The content focuses on governance structure and internal board committee regulations rather than financial results, audit opinions, or announcements of voting results. It is not an audit report, annual report, or any financial statement. It is also not a regulatory filing or announcement of a report publication. The document fits best under Governance Information (CGR) as it details the company's internal rules and governance practices related to the audit committee.
2023-10-26 Chinese
承诺管理制度
Governance Information Classification · 95% confidence The document is a formal announcement from the board of directors of Inner Mongolia Datang Pharmaceutical Co., Ltd. regarding the adoption and content of a commitment management system. It includes details about the board meeting, voting results, and the content of the governance system related to commitments by the company and related parties. The document does not contain financial statements, audit results, or earnings data. It is not a report itself but an announcement of a governance-related policy or system. The content focuses on governance rules and procedures, specifically about commitments and their management, which aligns with governance information. The document length is 2132 characters, which is relatively short and consistent with an announcement or governance document rather than a full report. Therefore, the most appropriate classification is Governance Information (CGR).
2023-10-26 Chinese
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for related party transactions of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the company's internal rules and procedures regarding related party transactions, including definitions, principles, approval processes, disclosure requirements, and governance. It includes references to board and shareholder meetings for approval of these rules. The content is focused on governance practices and internal control policies rather than financial results, audit opinions, or announcements of voting results. It is a detailed governance document about the company's internal rules and board procedures related to related party transactions. Therefore, it fits best under Governance Information (CGR). The document length is over 7000 characters, indicating it is the full text of the governance policy, not just an announcement or summary.
2023-10-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.